Peptide record

TPDB12632

Antibacterial Anticancer Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB12632
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
WWKAAAKAAAKWW
Physicochemical Analysis
C80H108N20O14
RNDCEQGHILMFPSTYV
A
1573.86
10.84
3
0
10
+3
-5.45
-0.346
46.15
Mammalian: 2.8 hour Yeast: 3 min E.coli: 2 min
22000
1397.83
0
Residue Composition
number
6
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
3
K
0
M
0
F
0
P
0
S
0
T
4
W
0
Y
0
V
Amino Acid Distribution
A: 6 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 3 M: 0 F: 0 P: 0 S: 0 T: 0 W: 4 Y: 0 V: 0
Chemical Descriptors
13
C80H108N20O14
1573.86
10.84
+3
-5.45
-0.346
Evidence Records 3 records
Evidence 1 Activity

Activity

5% Hemolysis
Toxicity
256 µM
Hemolytic Cytotoxic
5% Hemolysis | 256 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency. | Int J Mol Sci | 2019
Evidence 2 Activity

Activity

57% Killing
Toxicity
64 µM
Cytotoxic
57% Killing | 64 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency. | Int J Mol Sci | 2019
Evidence 3 Activity

Activity

% Hemolysis
Toxicity
24 %
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.30897850] 24% hemolysis at 256µM against human red blood cells | Cytotoxicity: [Ref.30897850] ①The cell viability of RAW 264.7 induced by WW is 104.3%, 103.6%, 109.4%, 103.6%, 97.5%, 89.9%, 63.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 µM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 µM.②The cell viability of HEK293T induced by WV is 102.9%, 111.6%, 105.1%, 104.3%, 101.8%, 84.8%, 43.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 µM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 µM.

Target

erythrocytes

Source & Reference

NA
DRAMP
Int J Mol Sci. 2019 Mar 20(6): 1417. Published online 2019 Mar 20. doi: 10.3390/ijms20061417